Effects of lumbar sympathetic ganglion block for a patient with amyotrophic lateral sclerosis (ALS)

被引：8

作者：

Kitoh T. ^{[1
]}

Kobayashi K. ^{[1
]}

Ina H. ^{[1
]}

Ofusa Y. ^{[1
]}

Otagiri T. ^{[1
]}

Tanaka S. ^{[2
]}

Ono K. ^{[2
]}

机构：

[1] Department of Anesthesiology and Resuscitology, Shinshu University School of Medicine, Matsumoto 390-8621

[2] Department of Anesthesia, Nagano Municipal Hospital, Nagano

来源：

Journal of Anesthesia | 2006年 / 20卷 / 2期

关键词：

Amyotrophic lateral sclerosis; Epidural block; Muscle weakness; Sympathetic ganglion block; Temperature;

D O I：

10.1007/s00540-005-0375-4

中图分类号：

学科分类号：

摘要：

A 59-year-old man with amyotrophic lateral sclerosis (ALS) received lumbar epidural and sympathetic ganglion blocks to increase regional blood flow and improve his clinical symptoms. After a lumbar epidural block (0.5% mepivacaine), the skin temperature of his affected lower extremities rose by 7.0°C and became close to that of the intact side, and the distance he was able to walk with his cane increased from 2 to 8m. The clinical effects produced by the lumbar sympathetic ganglion block (99.5% alcohol) were sustained for approximately 8 weeks after the first block and for approximately 6 weeks after the second block. There were no particular adverse effects or complications associated with these nerve block procedures. Epidural and sympathetic ganglion blocks for an ALS patient, albeit their effects are of a transient nature, may improve related clinical symptoms, and were thought to play a contributory role in improving our patient's quality of life. © JSA 2006.

引用

页码：109 / 112

页数：3

共 8 条

[1]

Lai E.C., Therapeutic developments in amyotrophic lateral sclerosis, Expert Opin Investig Drugs, 8, pp. 347-361, (1999)

[2]

Hiller A.D., Miller R.W., Yorkston K., McDonald E., Norris F.H., Konikow N., Amyotrophic lateral sclerosis severity scale, Neuroepidemiology, 8, pp. 142-150, (1989)

[3]

Otsuka N., Igarashi M., Shimodate Y., Nakabayashi K., Asano M., Namiki A., Anesthetic management of two patients with amyotrophic lateral sclerosis (ALS), Masui (Jpn J Anesthesiol), 53, pp. 1279-1281, (2004)

[4]

Mashio H., Ito Y., Yanagita Y., Fujisawa E., Hada K., Goda Y., Kawahigashi H., Anesthetic management of a patient with amyotrophic lateral sclerosis, Masui (Jpn J Anesthesiol), 49, pp. 191-194, (2000)

[5]

Terauchi Y., Treatment of muscular atrophy by regional nerve block, Lancet, 28, pp. 477-478, (1976)

[6]

Shindo K., Shimokawa C., Watanabe H., Iida H., Ohashi K., Nitta K., Nagasawa T., Tsunoda S., Shiozawa Z., Chronological changes of sympathetic outflow to muscles in amyotrophic lateral sclerosis, J Neurol Sci, 227, pp. 79-84, (2004)

[7]

Shindo K., Tsunoda S., Shiozawa Z., Increased sympathetic outflow to muscles in patients with amyotrophic lateral sclerosis: A comparison with other neuromuscular patients, J Neurol Sci, 134, pp. 57-60, (1995)

[8]

Yamamoto K., Sobue G., Iwase S., Mitsuma T., Mano T., Skin sympathetic nerve activity in amyotrophic lateral sclerosis, Rinsho Shinkeigaku (Clin Neurol), 34, pp. 377-380, (1994)

← 1 →